Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolomics in toxicology and preclinical research
Tzutzuy Ramı́rez
ALTEX (2013) Vol. 30, Iss. 2, pp. 209-225
Open Access | Times Cited: 200

Showing 1-25 of 200 citing articles:

Systems Toxicology: From Basic Research to Risk Assessment
Shana J. Sturla, Alan R. Boobis, Rex FitzGerald, et al.
Chemical Research in Toxicology (2014) Vol. 27, Iss. 3, pp. 314-329
Open Access | Times Cited: 319
Toxicity testing in the 21st century: progress in the past decade and future perspectives
Daniel Krewski, Melvin E. Andersen, Michael G. Tyshenko, et al.
Archives of Toxicology (2019) Vol. 94, Iss. 1, pp. 1-58
Closed Access | Times Cited: 293
Promises and Challenges of Big Data Computing in Health Sciences
Tao Huang, Liang Lan, Xuexian Fang, et al.
Big Data Research (2015) Vol. 2, Iss. 1, pp. 2-11
Closed Access | Times Cited: 199
State-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiology
Nathalie Alépée
ALTEX (2014), pp. 441-477
Open Access | Times Cited: 199
In vitro acute and developmental neurotoxicity screening: an overview of cellular platforms and high-throughput technical possibilities
Béla Z. Schmidt, Martin Lehmann, Simon Gutbier, et al.
Archives of Toxicology (2016) Vol. 91, Iss. 1, pp. 1-33
Open Access | Times Cited: 175
Use cases, best practice and reporting standards for metabolomics in regulatory toxicology
Mark R. Viant, Timothy M. D. Ebbels, Richard D. Beger, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 164
A review of environmental metabolism disrupting chemicals and effect biomarkers associating disease risks: Where exposomics meets metabolomics
Jiachen Sun, Runcheng Fang, Hua Wang, et al.
Environment International (2021) Vol. 158, pp. 106941-106941
Open Access | Times Cited: 124
The toxicity of nanoparticles and their interaction with cells: an in vitro metabolomic perspective
Mohammad Awashra, Piotr Młynarz
Nanoscale Advances (2023) Vol. 5, Iss. 10, pp. 2674-2723
Open Access | Times Cited: 96
Consensus report on the future of animal-free systemic toxicity testing
Marcel Leist
ALTEX (2014), pp. 341-356
Open Access | Times Cited: 172
“Omics”-Informed Drug and Biomarker Discovery: Opportunities, Challenges and Future Perspectives
Holly Matthews, James Hanison, Niroshini Nirmalan
Proteomes (2016) Vol. 4, Iss. 3, pp. 28-28
Open Access | Times Cited: 162
International STakeholder NETwork (ISTNET): creating a developmental neurotoxicity (DNT) testing road map for regulatory purposes
Anna Bal‐Price, Kevin M. Crofton, Marcel Leist, et al.
Archives of Toxicology (2015) Vol. 89, Iss. 2, pp. 269-287
Open Access | Times Cited: 147
Developmental neurotoxicity – Challenges in the 21st Century and In Vitro Opportunities
Lena Smirnova
ALTEX (2014)
Open Access | Times Cited: 145
Prediction of liver toxicity and mode of action using metabolomics in vitro in HepG2 cells
Tzutzuy Ramı́rez, Alexander Strigun, Andreas Verlohner, et al.
Archives of Toxicology (2017) Vol. 92, Iss. 2, pp. 893-906
Open Access | Times Cited: 142
Reference compounds for alternative test methods to indicate developmental neurotoxicity (DNT) potential of chemicals: example lists and criteria for their selection and use
Michael Aschner
ALTEX (2016)
Open Access | Times Cited: 139
Current and Future Perspectives on the Structural Identification of Small Molecules in Biological Systems
Daniel A. Dias, Oliver A.H. Jones, David J. Beale, et al.
Metabolites (2016) Vol. 6, Iss. 4, pp. 46-46
Open Access | Times Cited: 139
Good Cell Culture Practice for stem cells and stem-cell-derived models
David Pamies
ALTEX (2016)
Open Access | Times Cited: 123
Read-across approaches - misconceptions, promises and challenges ahead
Grace Patlewicz
ALTEX (2014) Vol. 31, Iss. 4, pp. 387-396
Open Access | Times Cited: 116
Design Principles of Concentration-Dependent Transcriptome Deviations in Drug-Exposed Differentiating Stem Cells
Tanja Waldmann, Eugen Rempel, Nina V. Balmer, et al.
Chemical Research in Toxicology (2014) Vol. 27, Iss. 3, pp. 408-420
Open Access | Times Cited: 110
Systems Toxicology: Real World Applications and Opportunities
Thomas Härtung, Rex FitzGerald, Paul Jennings, et al.
Chemical Research in Toxicology (2017) Vol. 30, Iss. 4, pp. 870-882
Open Access | Times Cited: 109
Genotoxicity testing: progress and prospects for the next decade
Hasan Türkez, Mehmet Enes Arslan, Özlem Özdemir Tozlu
Expert Opinion on Drug Metabolism & Toxicology (2017) Vol. 13, Iss. 10, pp. 1089-1098
Closed Access | Times Cited: 108
State-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiology
Nathalie Alépée
ALTEX (2014), pp. 441-477
Open Access | Times Cited: 106
Role of omics techniques in the toxicity testing of nanoparticles
Eleonore Fröhlich
Journal of Nanobiotechnology (2017) Vol. 15, Iss. 1
Open Access | Times Cited: 104
Toxicity testing in the 21st century beyond environmental chemicals
Costanza Rovida, Shoji Asakura, Mardas Daneshian, et al.
ALTEX (2015) Vol. 32, Iss. 3, pp. 171-181
Open Access | Times Cited: 101
Supporting read-across using biological data
Hao Zhu
ALTEX (2016), pp. 167-182
Open Access | Times Cited: 97
From targeted quantification to untargeted metabolomics: Why LC-high-resolution-MS will become a key instrument in clinical labs
Bertrand Rochat
TrAC Trends in Analytical Chemistry (2016) Vol. 84, pp. 151-164
Closed Access | Times Cited: 95
Page 1 - Next Page

Scroll to top